The MEngSc (Pharmaceutical and Biopharmaceutical Engineering) is a part-time programme running for a minimum of 24 months (maximum 60 months) from the date of first registration for the programme.
Candidates must have a BE (Hons) or BEng (Hons) Degree or equivalent engineering qualification, with a minimum grade 2H2, or a level 8 BSc degree, with a minimum grade 2H2, where the BSc graduate has a recognised qualification in Process or Chemical Engineering (e.g. the Diploma in Process and Chemical Engineering at UCC or equivalent). However, candidates with equivalent academic qualifications and suitable experience may be accepted subject to the approval of the Programme Director. In all cases, the course of study for each candidate must be approved by the Programme Director.
In Part I students take modules to the value of 60 credits. Taught
modules will be offered on a cyclical basis as detailed below.
Part II consists of a Dissertation to the value of 30 credits.
The choice of modules is subject to the approval of the Programme Director.
Students take 90 credits as follows:
Part I
Students take 60 credits from the following:
Offered in 2020/21
CM6010 Introductory Pharmaceutical Chemistry (5 credits)
PE6016 Pharmaceutical Industry; Manufacturing and Optimisation (5 credits)
PE6018 Pharmaceutical Process Validation and Quality (5 credits)
PE6022 Aseptic Manufacturing Design (5 credits)
PE6024 Advanced Process Design & Safety Engineering (5 credits)
PE6025 Advanced Health and Safety Management (5 credits)
PE6026 Project Engineering - From Concept to Completion (5 credits)
PF6302 Introduction to Pharmaceutics: Formulation Science (5 credits)
Offered in 2021/22
PE6010 Pharmaceutical Engineering (5 credits)
PE6011 Biopharmaceutical Engineering (5 credits)
PE6012 Pharmaceutical Process Equipment, Materials and Mechanical Design (5 credits)
PE6013 Powder and Particle Technology and Unit Operations (5 credits)
PE6015 Environmental Engineering in the Pharmaceutical Sector (5 credits)
PE6019 Process Analytical Technology (5 credits)
PE6023 Pharmaceutical and Biopharmaceutical Utilities (5 credits)
PE6027 Advanced Biopharmaceutical Engineering (5 credits)
Module Semester Information may be found here. Module Descriptions may be found here.
Part II
PE6021 Dissertation in Pharmaceutical and Biopharmaceutical
Engineering (30 credits)
Examinations
Full details and regulations governing Examinations for each programme
will be contained in the Marks and Standards 2020/2021 Book and for
each module in the Book of Modules, 2020/2021.
Postgraduate Diploma in Pharmaceutical and Biopharmaceutical
Engineering
Students who pass all modules in Part I but fail to achieve the
requisite grade of 50% across the taught modules will be eligible for
the award of a Postgraduate Diploma in Pharmaceutical and
Biopharmaceutical Engineering. A candidate who passes Part I of the
programme and who does not wish to proceed to Part II, may opt to be
conferred with a Postgraduate Diploma in Pharmaceutical and
Biopharmaceutical Engineering.
Individual Modules
Candidates who satisfy the programme eligibility criteria may, subject
to the approval of the Programme Coordinator, be permitted to take
individual modules, as part of UCC's commitment to Continuing
Professional Development (CPD), and be provided with a relevant
transcript of marks.
Programme Learning Outcomes for MEngSc in
Pharmaceutical and Biopharmaceutical Engineering (NFQ Level 9, Major
Award)
On successful completion of this programme, students should be able
to:
Programme Learning Outcomes for Postgraduate Diploma
in Pharmaceutical and Biopharmaceutical Engineering (NFQ Level 9,
Major Award)
On successful completion of this programme, students should
be able to: